Match tier
Listed
Presence
Current · Arkansas
Last published
2024
Sources
OpenAlex · ORCID
Refreshed
2026-10-07
A
Anne M. Hiegel
Role not yet determined Is this you? Add your title
Also affiliated: Arkansas Children's Hospital (2010–2023)
6 h-index
16 pubs
1,431 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Anne Hiegel's research focuses on pediatric food allergies, particularly peanut and tree nut allergies. Her work investigates the implementation of early introduction guidelines for these allergens among pediatric providers in the southern United States, including Arkansas. Hiegel also examines the outcomes and safety of oral food challenges for various allergens, including tree nuts and the "Big 9" allergens, in children and adolescents. Her publications explore predictors of success in oral food challenges and the safety of mixed tree nut challenges for children with multi-tree nut allergies. She has also published on oral immunotherapy for peanut allergy. Hiegel's scholarship metrics include an h-index of 6, with 16 total publications and 1,415 total citations.
Metrics
- h-index: 6
- Publications: 16
- Citations: 1,431
Selected Publications
-
Implementation of early peanut introduction among providers in a southern US state (2026)
-
Evaluating Oral Food Challenge Outcomes to the "Big 9” Allergens (2026)
-
Survey of Arkansas Pediatric Providers on the Application of the NIH/NIAID Addendum Guidelines for the Prevention of Peanut Allergy in the United States (2024)
-
Oral immunotherapy for peanut allergy (2023)
-
Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy (2013)
-
Sublingual versus oral immunotherapy for peanut-allergic children: A retrospective comparison (2013)
-
Comparison of Sublingual Immunotherapy (SLIT) versus Oral Immunotherapy (OIT) in the Treatment of Peanut Allergy (2012)
-
Development of Clinical Tolerance after Peanut OIT (2012)
-
Early and Persistent Gastrointestinal Side Effects Predict Withdrawal from Peanut Oral Immunotherapy (OIT) (2011)
-
A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response (2011)
-
Double-Blind, Placebo-Controlled Trial of Oral Immunotherapy (OIT) in Peanut (PN) Allergic Children: A Follow-up (2010)
-
Atopic dermatitis and food hypersensitivity reactions (1998)
Collaboration Network
Top Collaborators
Stacie M. Jones
Arkansas Children's Hospital
10 shared publications
In database
- A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response
- Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy
- Atopic dermatitis and food hypersensitivity reactions
- Sublingual versus oral immunotherapy for peanut-allergic children: A retrospective comparison
- Early and Persistent Gastrointestinal Side Effects Predict Withdrawal from Peanut Oral Immunotherapy (OIT)
Showing 5 of 10 shared publications
Amy M. Scurlock
Arkansas Children's Hospital
8 shared publications
In database
- A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response
- Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy
- Sublingual versus oral immunotherapy for peanut-allergic children: A retrospective comparison
- Early and Persistent Gastrointestinal Side Effects Predict Withdrawal from Peanut Oral Immunotherapy (OIT)
- Development of Clinical Tolerance after Peanut OIT
Showing 5 of 8 shared publications
A. Wesley Burks
Duke Medical Center (US)
8 shared publications
- A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response
- Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy
- Atopic dermatitis and food hypersensitivity reactions
- Sublingual versus oral immunotherapy for peanut-allergic children: A retrospective comparison
- Early and Persistent Gastrointestinal Side Effects Predict Withdrawal from Peanut Oral Immunotherapy (OIT)
Showing 5 of 8 shared publications
Pamela H. Steele
Duke Medical Center
7 shared publications
In database
- A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response
- Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy
- Sublingual versus oral immunotherapy for peanut-allergic children: A retrospective comparison
- Early and Persistent Gastrointestinal Side Effects Predict Withdrawal from Peanut Oral Immunotherapy (OIT)
- Development of Clinical Tolerance after Peanut OIT
Showing 5 of 7 shared publications
J. Kamilaris
Duke Medical Center (US)
7 shared publications
- A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response
- Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy
- Sublingual versus oral immunotherapy for peanut-allergic children: A retrospective comparison
- Early and Persistent Gastrointestinal Side Effects Predict Withdrawal from Peanut Oral Immunotherapy (OIT)
- Development of Clinical Tolerance after Peanut OIT
Showing 5 of 7 shared publications
Brian P. Vickery
Duke Medical Center (US)
7 shared publications
- A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response
- Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy
- Sublingual versus oral immunotherapy for peanut-allergic children: A retrospective comparison
- Early and Persistent Gastrointestinal Side Effects Predict Withdrawal from Peanut Oral Immunotherapy (OIT)
- Development of Clinical Tolerance after Peanut OIT
Showing 5 of 7 shared publications
Tamara T. Perry
Arkansas Children's Hospital
6 shared publications
In database
- A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response
- Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy
- Early and Persistent Gastrointestinal Side Effects Predict Withdrawal from Peanut Oral Immunotherapy (OIT)
- Development of Clinical Tolerance after Peanut OIT
- Double-Blind, Placebo-Controlled Trial of Oral Immunotherapy (OIT) in Peanut (PN) Allergic Children: A Follow-up
Showing 5 of 6 shared publications
S.K. Carlisle
Arkansas Children's Hospital
5 shared publications
In database
- Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy
- Sublingual versus oral immunotherapy for peanut-allergic children: A retrospective comparison
- Early and Persistent Gastrointestinal Side Effects Predict Withdrawal from Peanut Oral Immunotherapy (OIT)
- Development of Clinical Tolerance after Peanut OIT
- Comparison of Sublingual Immunotherapy (SLIT) versus Oral Immunotherapy (OIT) in the Treatment of Peanut Allergy
Mike Kulis
Duke Medical Center (US)
3 shared publications
- A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response
- Double-Blind, Placebo-Controlled Trial of Oral Immunotherapy (OIT) in Peanut (PN) Allergic Children: A Follow-up
- Comparison of Sublingual Immunotherapy (SLIT) versus Oral Immunotherapy (OIT) in the Treatment of Peanut Allergy
P. Brian Smith
Duke University (US)
3 shared publications
- Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy
- Sublingual versus oral immunotherapy for peanut-allergic children: A retrospective comparison
- Comparison of Sublingual Immunotherapy (SLIT) versus Oral Immunotherapy (OIT) in the Treatment of Peanut Allergy
Dieu Doan
Arkansas Children's Hospital
3 shared publications
In database
- Oral immunotherapy for peanut allergy
- Evaluating Oral Food Challenge Outcomes to the "Big 9” Allergens
- Implementation of early peanut introduction among providers in a southern US state
Pooja Varshney
Duke Medical Center (US)
2 shared publications
- A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response
- Sublingual versus oral immunotherapy for peanut-allergic children: A retrospective comparison
Michael D. Kulis
University of North Carolina at Chapel Hill (US)
2 shared publications
- Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy
- Sublingual versus oral immunotherapy for peanut-allergic children: A retrospective comparison
Robbie Pesek
Arkansas Children's Hospital
2 shared publications
In database
- Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy
- Survey of Arkansas Pediatric Providers on the Application of the NIH/NIAID Addendum Guidelines for the Prevention of Peanut Allergy in the United States
Molly Boone
Arkansas Children's Hospital
2 shared publications
In database
- Oral immunotherapy for peanut allergy
- Implementation of early peanut introduction among providers in a southern US state
Similar Researchers
Based on overlapping research topics
Scott L. Light
University of Arkansas for Medical Sciences
Food Allergy and Anaphylaxis Research
Child and Adolescent Health
Medical Case Studies
Allison Bruton
University of Arkansas for Medical Sciences
Food Allergy and Anaphylaxis Research
Child and Adolescent Health
Immune Response and Inflammation
Hannah Lewis
University of Arkansas for Medical Sciences
Child and Adolescent Health
Immune Response and Inflammation
Medical Case Studies
Carson Chappell
University of Arkansas for Medical Sciences
Food Allergy and Anaphylaxis Research
Child and Adolescent Health
Medical Case Studies
Peggy L. Chandler
University of Arkansas for Medical Sciences
Food Allergy and Anaphylaxis Research
Child and Adolescent Health
Medical Case Studies
Tyler Angtuaco
University of Arkansas for Medical Sciences
Food Allergy and Anaphylaxis Research
Child and Adolescent Health
Immune Response and Inflammation